Congenital myasthenic syndrome caused by a mutation in the Ets-binding site of the promoter region of the acetylcholine receptor epsilon subunit gene
- PMID: 10382905
- DOI: 10.1016/s0960-8966(99)00007-3
Congenital myasthenic syndrome caused by a mutation in the Ets-binding site of the promoter region of the acetylcholine receptor epsilon subunit gene
Abstract
Forty-two missense, truncation, or splice-site mutations of the acetylcholine receptor (AChR) subunit genes have been reported to date in patients with congenital myasthenic syndromes. Here we report a homozygous mutation, epsilon-155G --> A, in the promoter region of the AChR epsilon subunit gene that converts the Ets-binding site of the promoter region from CGGAA to CAGAA. The asymptomatic parents and brother are heterozygous and an affected sister is homozygous for epislon-155G --> A. The Ets-binding site mediates synapse specific expression of the AChR epsilon subunit gene. An identical G-to-A mutation in the mouse Ets-binding site was previously shown to decrease the binding affinity of the Ets-binding site for the GA binding protein, a transactivating factor for the Ets-binding site, and to reduce the synapse specific expression of the epsilon subunit. The decreased synaptic expression of the epsilon subunit readily accounts for the congenital myasthenic phenotype.
Comment in
-
A modified alignment of human and rodent 5' untranslated sequences of the acetylcholine receptor epsilon subunit gene reveals additional regions of high homology.Neuromuscul Disord. 2000 Mar;10(3):213-4. doi: 10.1016/s0960-8966(99)00112-1. Neuromuscul Disord. 2000. PMID: 10841620 No abstract available.
Similar articles
-
Congenital myasthenic syndromes due to heteroallelic nonsense/missense mutations in the acetylcholine receptor epsilon subunit gene: identification and functional characterization of six new mutations.Hum Mol Genet. 1997 May;6(5):753-66. doi: 10.1093/hmg/6.5.753. Hum Mol Genet. 1997. PMID: 9158150
-
Mutation of the acetylcholine receptor epsilon-subunit promoter in congenital myasthenic syndrome.Ann Neurol. 1999 Apr;45(4):439-43. Ann Neurol. 1999. PMID: 10211467
-
[Congenital myasthenic syndrome related to homozygous missense mutation in promoter region of acetylcholine receptor epsilon-subunit gene].Zh Nevrol Psikhiatr Im S S Korsakova. 2004;104(4):55-7. Zh Nevrol Psikhiatr Im S S Korsakova. 2004. PMID: 15270301 Russian. No abstract available.
-
Congenital myasthenic syndromes: recent advances.Arch Neurol. 1999 Feb;56(2):163-7. doi: 10.1001/archneur.56.2.163. Arch Neurol. 1999. PMID: 10025421 Review.
-
Congenital myasthenic syndromes: experiments of nature.J Physiol Paris. 1998 Apr;92(2):113-7. doi: 10.1016/S0928-4257(98)80147-2. J Physiol Paris. 1998. PMID: 9782453 Review.
Cited by
-
HnRNP C, YB-1 and hnRNP L coordinately enhance skipping of human MUSK exon 10 to generate a Wnt-insensitive MuSK isoform.Sci Rep. 2014 Oct 30;4:6841. doi: 10.1038/srep06841. Sci Rep. 2014. PMID: 25354590 Free PMC article.
-
A 3D culture model of innervated human skeletal muscle enables studies of the adult neuromuscular junction.Elife. 2019 May 14;8:e44530. doi: 10.7554/eLife.44530. Elife. 2019. PMID: 31084710 Free PMC article.
-
Targeting of the ETS factor GABPalpha disrupts neuromuscular junction synaptic function.Mol Cell Biol. 2007 May;27(9):3470-80. doi: 10.1128/MCB.00659-06. Epub 2007 Feb 26. Mol Cell Biol. 2007. PMID: 17325042 Free PMC article.
-
Current status of the congenital myasthenic syndromes.Neuromuscul Disord. 2012 Feb;22(2):99-111. doi: 10.1016/j.nmd.2011.10.009. Epub 2011 Nov 21. Neuromuscul Disord. 2012. PMID: 22104196 Free PMC article. Review.
-
The Ets transcription factor GABP is required for postsynaptic differentiation in vivo.J Neurosci. 2000 Aug 15;20(16):5989-96. doi: 10.1523/JNEUROSCI.20-16-05989.2000. J Neurosci. 2000. PMID: 10934247 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
